This invention relates to the field of
biomedical technology, specifically disclosing a polypeptide and its application in the preparation of drugs for
ischemic stroke. The
amino acid sequence of the polypeptide is shown in SEQ ID NO. 1. This invention utilizes an
in vivo tMCAO / R model and
in vitro studies covering
ischemic hypoxia (OGD) and
neurotoxicity (MPP). + Multiple
cell models of NL-PT, including those for cellular stress and hormonal stress (CORT), were used to reveal the application potential of the
peptide NL-PT from multiple dimensions and levels. These results collectively demonstrate that NL-PT not only has a significant protective effect against the core
pathological processes of
ischemic stroke, but also exhibits broad-spectrum
biological activity against various related injuries. In particular, its well-defined mechanism of anti-
oxidative stress through
scavenging reactive oxygen species (ROS) further highlights its multi-target intervention characteristics, providing
solid and reliable experimental evidence for its development into a novel, multi-target therapeutic
drug for
ischemic stroke.